Ribupatide
HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction
Fujian Shengdi Pharmaceutical Co · Phase 2 · Active, not recruiting · Enrollment 203
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| HRS9531 | Heart Failure With Preserved Ejection Fraction | n/r | n/r | n/r | n/r |
| Placebo | Heart Failure With Preserved Ejection Fraction | n/r | n/r | n/r | n/r |